Nicola Fusco Biobank for Translational and Digital Medicine Unit IEO, European Institute of Oncology IRCCS Biography Publications Institution JoVE Articles Nicola Fusco has not added a biography. If you are Nicola Fusco and would like to personalize this page please email our Author Liaison for assistance. Publications Breast Cancer During Pregnancy As a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles Cells. Jul, 2022 | Pubmed ID: 35892583 Association Between Previous Negative Biopsies and Lower Rates of Progression During Active Surveillance for Prostate Cancer World Journal of Urology. Jun, 2022 | Pubmed ID: 35347414 Low-risk Triple-negative Breast Cancers: Clinico-pathological and Molecular Features Critical Reviews in Oncology/hematology. Apr, 2022 | Pubmed ID: 35217131 Active Surveillance for Prostate Cancer: Comparison Between Incidental Tumors Vs. Tumors Diagnosed at Prostate Biopsies World Journal of Urology. Feb, 2022 | Pubmed ID: 34687344 Repeat MRI During Active Surveillance: Natural History of Prostatic Lesions and Upgrading Rates BJU International. Apr, 2022 | Pubmed ID: 34687137 Combined Analysis of PTEN, HER2, and Hormone Receptors Status: Remodeling Breast Cancer Risk Profiling BMC Cancer. Oct, 2021 | Pubmed ID: 34706703 Assessment of Estrogen Receptor Low Positive Status in Breast Cancer: Implications for Pathologists and Oncologists Histology and Histopathology. Dec, 2021 | Pubmed ID: 34585734 Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study Frontiers in Oncology. 2021 | Pubmed ID: 34504801 Mismatch Repair-deficient Hormone Receptor-positive Breast Cancers: Biology and Pathological Characterization Cancer Cell International. May, 2021 | Pubmed ID: 34001143 Understanding the Biology of Volumetric Muscle Loss for an Individualized Exercise Rehabilitation Approach in Breast Cancer Patients Current Opinion in Pharmacology. Jun, 2021 | Pubmed ID: 33848933 Characterization of the Immune Microenvironment in Malignant Pleural Mesothelioma Reveals Prognostic Subgroups of Patients Lung Cancer (Amsterdam, Netherlands). Dec, 2020 | Pubmed ID: 33065463 Cellular Immunotherapy in Breast Cancer: The Quest for Consistent Biomarkers Cancer Treatment Reviews. Nov, 2020 | Pubmed ID: 32889360 Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record Cancers. Jul, 2020 | Pubmed ID: 32635634 Spinal Cord Injury As a Model of Bone-Muscle Interactions: Therapeutic Implications From and Studies Frontiers in Endocrinology. 2020 | Pubmed ID: 32351450 RE: Mismatch Repair Protein Loss in Breast Cancer: Clinicopathological Associations in a Large British Columbia Cohort Breast Cancer Research and Treatment. Feb, 2020 | Pubmed ID: 31950382 Myostatin As a Potential Biomarker to Monitor Sarcopenia in Hip Fracture Patients Undergoing a Multidisciplinary Rehabilitation and Nutritional Treatment: a Preliminary Study Aging Clinical and Experimental Research. May, 2020 | Pubmed ID: 31838642 Targeting Immune-Related Biological Processes in Solid Tumors: We Do Need Biomarkers International Journal of Molecular Sciences. Nov, 2019 | Pubmed ID: 31683784 Diagnostic Challenge of Intrathoracic Tissue Misplacements: a Thymic Choristoma in a Fetal Lung Thorax. 06, 2019 | Pubmed ID: 30940769 Alterations Are Linked to Increased HER2 Expression in Breast Cancer-Letter Cancer Prevention Research (Philadelphia, Pa.). 03, 2019 | Pubmed ID: 30792346 Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors International Journal of Molecular Sciences. Jan, 2019 | Pubmed ID: 30691046 Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab Journal of Clinical Medicine. Jan, 2019 | Pubmed ID: 30682851 Tackling the Diversity of Breast Cancer Related Lymphedema: Perspectives on Diagnosis, Risk Assessment, and Clinical Management Breast (Edinburgh, Scotland). Apr, 2019 | Pubmed ID: 30580170 Molecular Signatures of Medullary Thyroid Carcinoma by Matrix-assisted Laser Desorption/ionisation Mass Spectrometry Imaging Journal of Proteomics. 01, 2019 | Pubmed ID: 29581064 Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma International Journal of Molecular Sciences. Oct, 2018 | Pubmed ID: 30282914 Lymphovascular Invasion and Extranodal Tumour Extension Are Risk Indicators of Breast Cancer Related Lymphoedema: an Observational Retrospective Study with Long-term Follow-up BMC Cancer. Sep, 2018 | Pubmed ID: 30268112 Biobank för translationell medicin: Standardrutiner för optimal provhantering Giuseppina Bonizzi*1, Maria Capra*1, Cristina Cassi1, Giulio Taliento1, Oriana Pala2, Elham Sajjadi2,3, Konstantinos Venetis2,3, Mariia Ivanova2, Massimo Monturano4, Giuseppe Renne2, Lorenzo Zattoni1,3, Elena Guerini-Rocco2,3, Giuseppe Viale2,3, Roberto Orecchia5, Nicola Fusco1,2,3 1Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS, 2Division of Pathology, IEO, European Institute of Oncology IRCCS, 3Department of Oncology and Hemato-Oncology, University of Milan, 4Patient Safety & Risk Management Service, IEO, European Institute of Oncology IRCCS, 5Scientific Directorate, IEO, European Institute of Oncology IRCCS JoVE 63950 Cancer Research Integrera Augmented Reality Tools in Breast Cancer Related Lymfödem Prognostication and Diagnosis Marco Invernizzi1, Letterio Runza2, Alessandro De Sire1, Lorenzo Lippi1, Concetta Blundo3, Donatella Gambini4, Renzo Boldorini5,6, Stefano Ferrero2,7, Nicola Fusco2,7 1Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont "A. Avogadro", 2Division of Pathology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 3Division of Breast Surgery, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 4Division of Medical Oncology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 5Division of Pathology, Maggiore della Carità Hospital, 6Department of Health Sciences, University of Eastern Piedmont "A. Avogadro", 7Department of Biomedical, Surgical, and Dental Sciences, University of Milan JoVE 60093 Medicine Bygga upp en High-throughput Screening plattform att bedöma heterogenitet HER2 genen amplifiering i bröstcancer Giulia Ercoli1, Gianluca Lopez1,2, Camilla Ciapponi1,3, Chiara Corti1,2, Luca Despini4, Donatella Gambini5, Letterio Runza1, Concetta Blundo4, Amedeo Sciarra1, Nicola Fusco1,6 1Division of Pathology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 2School of Medicine, University of Milan, 3School of Biology, University of Pavia, 4Division of Breast Surgery, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 5Division of Medical Oncology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 6Department of Biomedical, Surgical, and Dental Sciences, University of Milan JoVE 56686 Immunology and Infection
Biobank för translationell medicin: Standardrutiner för optimal provhantering Giuseppina Bonizzi*1, Maria Capra*1, Cristina Cassi1, Giulio Taliento1, Oriana Pala2, Elham Sajjadi2,3, Konstantinos Venetis2,3, Mariia Ivanova2, Massimo Monturano4, Giuseppe Renne2, Lorenzo Zattoni1,3, Elena Guerini-Rocco2,3, Giuseppe Viale2,3, Roberto Orecchia5, Nicola Fusco1,2,3 1Biobank for Translational and Digital Medicine Unit, IEO, European Institute of Oncology IRCCS, 2Division of Pathology, IEO, European Institute of Oncology IRCCS, 3Department of Oncology and Hemato-Oncology, University of Milan, 4Patient Safety & Risk Management Service, IEO, European Institute of Oncology IRCCS, 5Scientific Directorate, IEO, European Institute of Oncology IRCCS JoVE 63950 Cancer Research
Integrera Augmented Reality Tools in Breast Cancer Related Lymfödem Prognostication and Diagnosis Marco Invernizzi1, Letterio Runza2, Alessandro De Sire1, Lorenzo Lippi1, Concetta Blundo3, Donatella Gambini4, Renzo Boldorini5,6, Stefano Ferrero2,7, Nicola Fusco2,7 1Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont "A. Avogadro", 2Division of Pathology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 3Division of Breast Surgery, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 4Division of Medical Oncology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 5Division of Pathology, Maggiore della Carità Hospital, 6Department of Health Sciences, University of Eastern Piedmont "A. Avogadro", 7Department of Biomedical, Surgical, and Dental Sciences, University of Milan JoVE 60093 Medicine
Bygga upp en High-throughput Screening plattform att bedöma heterogenitet HER2 genen amplifiering i bröstcancer Giulia Ercoli1, Gianluca Lopez1,2, Camilla Ciapponi1,3, Chiara Corti1,2, Luca Despini4, Donatella Gambini5, Letterio Runza1, Concetta Blundo4, Amedeo Sciarra1, Nicola Fusco1,6 1Division of Pathology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 2School of Medicine, University of Milan, 3School of Biology, University of Pavia, 4Division of Breast Surgery, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 5Division of Medical Oncology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 6Department of Biomedical, Surgical, and Dental Sciences, University of Milan JoVE 56686 Immunology and Infection
